Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 15, 641-643, November 1, 1955]
© 1955 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Werkheiser, W. C.
Right arrow Articles by Visser, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Werkheiser, W. C.
Right arrow Articles by Visser, D. W.

Metabolic Inhibitors and Nucleotide Turnover

I. Inhibition of Uptake of Radiophosphate in Rat Liver and Hepatoma Slices*

William C. Werkheiser{dagger}, Richard J. Winzler{ddagger} and Donald W. Visser

( Department of Biochemistry and Nutrition, University of Southern California, Los Angeles, California)

The purine analog, 2,6-diaminopurine, and the pyrimidine nucleoside analog, 5-aminouridine, have been shown to reduce the incorporation of radioactive phosphate into the phospholipids and the ribonucleic acid nucleotides of slices of rat liver and a rat hepatoma. 5-Aminouridine appeared somewhat more effective in liver than in hepatoma, while 2,6-diaminopurine was more effective in hepatoma. Inhibition by aminouridine was nearly uniform in all fractions in both tissues, while that by diaminopurine was greater in the purine nucleotides in liver and in adenylic acid in hepatoma.

Differences between the metabolism of liver and hepatoma slices have been observed. Furthermore, purine and pyrimidine analogs have each been shown to inhibit incorporation into both purine and pyrimidine nucleotides, as well as that into phospholipids.

* This work was supported in part by a grant from the California Section of the American Cancer Society and from the National Institutes of Health. Some of the facilities were made available by the Allan Hancock Foundation.

{dagger} Present address: Department of Biochemistry, Oxford University, Oxford, England.

{ddagger} Present address: Department of Biological Chemistry, University of Illinois College of Medicine, Chicago, Illinois.

Received 11/29/54.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1955 by the American Association for Cancer Research.